2m 2m 2m 2m 2m 2m 2m
Bristol-MyersSqu (BMY)
NYSE
$63.53+$0.62 (+0.98%)
Price as of Nov 12, 2026 8:20 AM EST- $128.6BMarket Cap
- 33.88%1-Year Change
- Drug Manufacturers - GeneralIndustry
Bristol-MyersSqu (BMY)
$63.53+$0.62 (+0.98%)
BMY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $62.91 | ||
Change | +$0.11 (+0.18%) | ||
Open | $62.00 | ||
High | $62.96 | ||
Low | $61.31 | ||
Previous Close | $62.80 | ||
Volume | 6,429,831 | ||
30-Day Average Volume | 11,512,974 | ||
1-Week Change | -1.99% | ||
1-Month Change | 6.41% | ||
1-Year Change | 33.88% | ||
3-Year Change | 43.18% | ||
5-Year Change | 30.73% | ||
Fundamentals | |||
Shares Outstanding | 2.0B | ||
Total Assets | $88.8B | ||
Market Cap | $128.6B | ||
Enterprise Value | $161.9B | ||
Period: QTR TTM FY | |||
Revenue | $12.6B | ||
Net Income | $2.2B | ||
Free Cash Flow | $3.8B | ||
EBIT | $2.5B | ||
EBITDA | $3.2B | ||
Net Working Capital | $11.0B | ||
EPS | $1.05 | ||
Enterprise Value/EBITDA | 51 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 5 | ||
P/E | 60 | ||
PEG | -2 | ||
Price/Free Cash Flow | 34 | ||
Price/Operating Cash Flow | 31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 4.01% | ||
Trailing Annual Dividend Yield | 4.01% | ||
Ex-Dividend Date | 10/02/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield